Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

@article{CroninFenton2016LowdoseAN,
  title={Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.},
  author={Deirdre P. Cronin-Fenton and Uffe heide-J\orgensen and Thomas P Ahern and Timothy Lee Lash and Peer Michael Christiansen and Bent Ejlertsen and Henrik Toft S\orensen},
  journal={Epidemiology},
  year={2016},
  volume={27 4},
  pages={586-93}
}
BACKGROUND Aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast cancer recurrence. METHODS We identified incident stage I-III Danish breast cancer patients in the Danish Breast Cancer Cooperative Group registry, who were diagnosed during 1996-2008. Prescriptions for aspirin (>99% low-dose aspirin), NSAIDs, and… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 48 references

A Randomised Controlled Phase II Trial of PreOperative Celecoxib Treatment Reveals Anti-Tumour Transcriptional Response in Primary Breast Cancer

  • RD Brandao, J Veeck, KK Van de Vijver
  • Breast Cancer Res
  • 2013

Similar Papers

Loading similar papers…